The latest news from the Immunology Center of Georgia
The IMMCG Newsroom is your hub for the latest news, stories, and media coverage from the Immunology Center of Georgia (IMMCG), part of the Medical College of Georgia at 麻豆AV. Here you鈥檒l find recent Jagwire articles, public鈥慺acing newsletters, and an 鈥淚n the News鈥� section highlighting external media coverage featuring our scientists and trainees, along with videos from our YouTube channel. Check back often to stay up to date on the people, discoveries, and events shaping IMMCG.
IMMCG researcher wins 'Biomedicines' Young Investigator Award
麻豆AV sets donor record, raises $629K on giving day
Hedrick named to boards of immunology conference, Georgia Research Alliance聽
IMMCG in the news
Top 6 stories:
Expanse Supercomputer Used for Breakthrough Immunotherapy Study
A groundbreaking discovery published in Nature Immunology has shed light on why the immune system is less aggressive toward self-antigens, offering new opportunities to enhance cancer immunotherapy.
麻豆AV researcher receives grant to study link between cancer, cardiovascular disease
A researcher at 麻豆AV鈥檚 Immunology Center of Georgia has been awarded the center鈥檚 first American Heart Association Postdoctoral Fellowship to support innovative research into the link between cancer and cardiovascular disease.
麻豆AV | Healthcare Workforce: A Prescription for the Future
Russell Keen, president of 麻豆AV, presided over the opening of AU-Medical College of Georgia鈥檚 Savannah campus, increasing enrollment and moving the school into the top five in the nation for class size.
AU immunologist earns NIH grant to study chronic inflammatory diseases
Rafael Czepielewski, PhD, at the Immunology Center of Georgia, received the MIST Scholar Award from the NIH to fund research on the interplay between the immune system and lymphatic vasculature in chronic conditions.
The HPV breakdown: Why you should 'Gard' your health
Each year, 13 million Americans become infected with HPV. While most show no symptoms, at least a dozen types can lead to cancer, causing 36,000 cases in the United States annually.
CD73 and PD-1 gatekeep self-reactive CD4+ T cell expansion
In a recent Nature Immunology publication, researchers explored the mechanisms responsible for the limited immune response to self-antigens, even upon vaccination, essential for preventing autoreactivity.
IMMCG Newsletters
| Year | Spring/Fall | Newsletters |
| 2025 | Fall | |
| 2025 | Spring | |
| 2024 | Fall | |
| 2024 | Spring |